Home LiteratureArticle Details
PMID: 1677144 Published · ppublish English Case Reports Clinical Trial Letter Comment

CD4 antibody treatment of severe psoriasis.

Lancet (London, England) ·Vol. 338 ·No. 8762 ·1991-08-03 ·Pages 321

Nicolas JF, Chamchick N, Thivolet J, Wijdenes J, Morel P, Revillard JP

Abstract

暂无摘要

MeSH Terms
Adult Antibodies, Monoclonal/therapeutic use CD4 Antigens/immunology Drug Administration Schedule Humans Male Middle Aged Psoriasis/drug therapy
Chemicals
Antibodies, Monoclonal CD4 Antigens
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Nicolas J F
Chamchick N
Thivolet J
Wijdenes J
Morel P
Revillard J P
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/0140-6736(91)90465-2
Published
1991-08-03
Pages
321
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 1675339
External Links
PubMed source DOI: 10.1016/0140-6736(91)90465-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2